IndiaTickerVenmax Drugs and Pharmaceuticals Ltd - 531015 - Announcement under Regulation 30 (LODR)-AllotmentBSE · exchange filing · pdf
Source filing Company dossier
Venmax Drugs & Pharmaceuticals
BSE:VENMAX · ISIN INE154G01022
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Venmax Drugs & Pharmaceuticals
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Venmax Drugs and Pharmaceuticals Ltd - 531015 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Closure of Trading WindowBSE · financial results · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Statement Of Deviation & VariationBSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended March 31, 2026BSE · financial results · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Audited Financial Results For The Quarter And Year Ended March 31, 2026BSE · financial results · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Intimation for Audited Standalone Financial Results Of The Company For The Quarter And Year Ended March 31, 2026.BSE · financial results · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Regulation 31(4) - SAST DisclosureBSE · shareholding · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Outcome for Modification Of Draft Scheme Of AmalgamationBSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Closure of Trading WindowBSE · financial results · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Announcement under Regulation 30 (LODR)-AllotmentBSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025.BSE · financial results · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Statement Of Deviation And Variation For The Quarter Ended December 31, 2025.BSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025.BSE · financial results · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter Ended December 31, 2025.BSE · financial results · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Conversion Of Share Warrants Into EquityBSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Announcement under Regulation 30 (LODR)-Resignation of DirectorBSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Announcement under Regulation 30 (LODR)-Resignation of DirectorBSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Outcome for Outcome Of The Board MeetingBSE · financial results · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025.BSE · financial results · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter Ended September 30, 2025.BSE · financial results · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Outcome for Revised Outcome Of Board MeetingBSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Outcome for Outcome Of The Board MeetingBSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.BSE · exchange filing · pdf
Source filing Venmax Drugs and Pharmaceuticals Ltd - 531015 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing